New Delhi [India], May 2 (ANI): The COVID-19 working group of the National Technical Advisory Group on Immunisation (NTAGI) will review the data of COVID-19 vaccines for the children aged 5 to 12 years on May 4, said sources on Monday.
New Delhi [India], April 30 (ANI): The National Technical Advisory Group on Immunisation (NTAGI) recommended that the Russian COVID-19 vaccine Sputnik Light which contains the same ingredients as the first dose of Sputnik V can be taken as a precaution dose, said Sources.
New Delhi [India], April 29 (ANI): National Technical Advisory Group on Immunisation (NTAGI) on Friday approved Serum Institute of India's Covovax COVID-19 vaccine for the age group 12-17, said sources.
New Delhi [India] April 27 (ANI/PNN): Women, children and adolescents, and the health and aid workers who provide their care and support, are facing growing challenges and life-threatening risks in these times of escalating conflict and humanitarian crises worldwide, according to a commentar
New Delhi [India], April 11 (ANI): New COVID-19 variants will keep coming, however, the new variants aren't causing severe diseases or increasing the number of cases said Chairman of the COVID-19 working group of India, National Technical Advisory Group on Immunisation (NTAGI), Dr NK Aror
New Delhi [India], April 8 (ANI): With a continuous decline in COVID-19 cases in the country, the Indian Sars-CoV-2 Genomic Consortium (INSACOG) has started surveillance of sewage water at 19 different sites in 15 States to detect the presence of the Sars-CoV-2 virus.
New Delhi [India], March 30 (ANI): The COVID-19 working group of the National Technical Advisory on Immunisation (NTAGI) will be reviewing the data of Serum Institute of India's vaccine -- Covovax for use for children and adults, on April 1, sources informed on Wednesday.
New Delhi [India], March 15 (ANI): The primary focus was immunisation of children with comorbidities but due to the unavailability of data of such children, we have decided to open immunization for all the children between the age group of 12-15 years, said Dr NK Arora, Chairman of COVID-
New Delhi [India], February 15 (ANI): India's third homegrown COVID-19 vaccine Corbevax is safe and offers good immunogenicity and higher antibody levels than some other vector vaccines, said Dr N K Arora, Chairman, India's COVID-19 Working group of National Technical Advisory Group on immun
New Delhi [India], January 11 (ANI): Molnupiravir, an oral antiviral drug used in the treatment of COVID-19 should not be administered to the younger population as it adversely affects their reproductive system, said Dr NK Arora, Chairman of COVID-19 Working Group of National Technical Advis
Islamabad [Pakistan], December 30 (ANI): Unhygienic atmosphere and lack of family planning are attributed to malnutrition and early death among children in Pakistan.
New Delhi [India], December 26 (ANI): Covaxin has shown that it has a very good immune response in children in trials, Dr NK Arora, Chairman of Covid Task Force working group, NTAGI, said on Sunday.